Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases
The ratio of angiopoietins ANG‐1 and ANG‐2 regulates vessel quiescence and neoangiogenesis as well as barrier function. It also acts as a switch from health to neovascular eye diseases.
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
14 October 2016
|
| In: |
EMBO molecular medicine
Year: 2016, Jahrgang: 8, Heft: 11, Pages: 1265-1288 |
| ISSN: | 1757-4684 |
| DOI: | 10.15252/emmm.201505889 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.15252/emmm.201505889 Verlag, lizenzpflichtig, Volltext: https://www.embopress.org/doi/abs/10.15252/emmm.201505889 
|
| Verfasserangaben: | Jörg T. Regula, Peter Lundh von Leithner, Richard Foxton, Veluchamy A. Barathi, Chui Ming Gemmy Cheung, Sai Bo Bo Tun, Yeo Sia Wey, Daiju Iwata, Miroslav Dostalek, Jörg Moelleken, Kay G. Stubenrauch, Everson Nogoceke, Gabriella Widmer, Pamela Strassburger, Michael J. Koss, Christian Klein, David T. Shima & Guido Hartmann |
| Zusammenfassung: | The ratio of angiopoietins ANG‐1 and ANG‐2 regulates vessel quiescence and neoangiogenesis as well as barrier function. It also acts as a switch from health to neovascular eye diseases. |
|---|---|
| Beschreibung: | Gesehen am 19.02.2021 |
| Beschreibung: | Online Resource |
| ISSN: | 1757-4684 |
| DOI: | 10.15252/emmm.201505889 |